nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfisoxazole—CYP2C9—Donepezil—Alzheimer's disease	0.783	1	CbGbCtD
Sulfisoxazole—EDNRA—Endothelin Pathways—NPY—Alzheimer's disease	0.00922	0.0443	CbGpPWpGaD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—PTGS1—Alzheimer's disease	0.0091	0.0438	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—PLCB1—Alzheimer's disease	0.0074	0.0356	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—PTK2B—Alzheimer's disease	0.00493	0.0237	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—CALM1—Alzheimer's disease	0.00473	0.0228	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—PLCB1—Alzheimer's disease	0.00441	0.0212	CbGpPWpGaD
Sulfisoxazole—CYP2C9—CYP2E1 reactions—CYP2D6—Alzheimer's disease	0.00429	0.0206	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—PYY—Alzheimer's disease	0.00417	0.0201	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00397	0.0191	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelin Pathways—NOS3—Alzheimer's disease	0.00353	0.017	CbGpPWpGaD
Sulfisoxazole—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—Alzheimer's disease	0.00349	0.0168	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—PRKCG—Alzheimer's disease	0.00326	0.0157	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—GAL—Alzheimer's disease	0.00289	0.0139	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.0028	0.0135	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR6—Alzheimer's disease	0.00273	0.0131	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide GPCRs—CCR5—Alzheimer's disease	0.00272	0.0131	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Xenobiotics—CYP2D6—Alzheimer's disease	0.00266	0.0128	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00255	0.0123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00249	0.012	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.00245	0.0118	CbGpPWpGaD
Sulfisoxazole—Dapsone—MPO—Alzheimer's disease	0.00235	0.247	CrCbGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.00234	0.0112	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—CCR5—Alzheimer's disease	0.0023	0.0111	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—NPY—Alzheimer's disease	0.00227	0.0109	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Other—HTR2A—Alzheimer's disease	0.00225	0.0108	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—PYY—Alzheimer's disease	0.00213	0.0103	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—NPS—Alzheimer's disease	0.00211	0.0101	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—NPS—Alzheimer's disease	0.00208	0.01	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.00202	0.0097	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—SST—Alzheimer's disease	0.00198	0.00954	CbGpPWpGaD
Sulfisoxazole—Sulfamethoxazole—PTGS1—Alzheimer's disease	0.00197	0.207	CrCbGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—APP—Alzheimer's disease	0.00196	0.00941	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.00194	0.00933	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—APP—Alzheimer's disease	0.00193	0.0093	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.00188	0.00906	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.00185	0.00888	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR6—Alzheimer's disease	0.00178	0.00856	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.00175	0.00842	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.00165	0.00794	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—MAPK8—Alzheimer's disease	0.00164	0.00791	CbGpPWpGaD
Sulfisoxazole—Sulfaphenazole—CYP2D6—Alzheimer's disease	0.00158	0.167	CrCbGaD
Sulfisoxazole—Dapsone—PTGS1—Alzheimer's disease	0.00154	0.162	CrCbGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.00152	0.00733	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.00151	0.00725	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—GAL—Alzheimer's disease	0.00148	0.00711	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.00139	0.00671	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.00136	0.00655	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.00133	0.0064	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.0013	0.00626	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.0013	0.00623	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCR5—Alzheimer's disease	0.00128	0.00615	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.00127	0.00609	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PYY—Alzheimer's disease	0.00121	0.0058	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.0012	0.00579	CbGpPWpGaD
Sulfisoxazole—Sulfanilamide—CYP2D6—Alzheimer's disease	0.00118	0.124	CrCbGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—NPY—Alzheimer's disease	0.00116	0.00558	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—IAPP—Alzheimer's disease	0.00115	0.00555	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.00113	0.00545	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CRH—Alzheimer's disease	0.00112	0.00539	CbGpPWpGaD
Sulfisoxazole—EDNRA—G alpha (q) signalling events—F2—Alzheimer's disease	0.00111	0.00534	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.0011	0.0053	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—F2—Alzheimer's disease	0.0011	0.00527	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PYY—Alzheimer's disease	0.00109	0.00526	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.00109	0.00524	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.00107	0.00515	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—NPS—Alzheimer's disease	0.00106	0.00511	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.00106	0.00508	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—SST—Alzheimer's disease	0.00101	0.00487	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR6—Alzheimer's disease	0.00101	0.00484	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.001	0.00481	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.000993	0.00478	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—APP—Alzheimer's disease	0.000987	0.00475	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000979	0.00471	CbGpPWpGaD
Sulfisoxazole—EDNRA—Peptide ligand-binding receptors—CCL2—Alzheimer's disease	0.000977	0.0047	CbGpPWpGaD
Sulfisoxazole—EDNRA—Endothelins—AKT1—Alzheimer's disease	0.000968	0.00466	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CDK5—Alzheimer's disease	0.000949	0.00456	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR6—Alzheimer's disease	0.000913	0.00439	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000912	0.00439	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000905	0.00435	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000894	0.0043	CbGpPWpGaD
Sulfisoxazole—Dapsone—PTGS2—Alzheimer's disease	0.000881	0.0927	CrCbGaD
Sulfisoxazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000863	0.00415	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000857	0.00412	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000839	0.00403	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GAL—Alzheimer's disease	0.000835	0.00402	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GAL—Alzheimer's disease	0.000758	0.00365	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TTR—Alzheimer's disease	0.00074	0.00356	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000735	0.00354	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPY—Alzheimer's disease	0.000656	0.00316	CbGpPWpGaD
Sulfisoxazole—EDNRA—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000656	0.00315	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCR5—Alzheimer's disease	0.000653	0.00314	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000652	0.00314	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PYY—Alzheimer's disease	0.000646	0.00311	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	0.000639	0.00307	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000639	0.00307	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CRH—Alzheimer's disease	0.000633	0.00304	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000616	0.00296	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—NPS—Alzheimer's disease	0.0006	0.00289	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPY—Alzheimer's disease	0.000596	0.00287	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IAPP—Alzheimer's disease	0.000592	0.00285	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CRH—Alzheimer's disease	0.000575	0.00276	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000572	0.00275	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—SST—Alzheimer's disease	0.000572	0.00275	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CDK5—Alzheimer's disease	0.00056	0.0027	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—F2—Alzheimer's disease	0.00056	0.00269	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—APP—Alzheimer's disease	0.000558	0.00268	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—NPS—Alzheimer's disease	0.000545	0.00262	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000542	0.00261	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR6—Alzheimer's disease	0.00054	0.00259	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000526	0.00253	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—SST—Alzheimer's disease	0.00052	0.0025	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—GAB2—Alzheimer's disease	0.00052	0.0025	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—APP—Alzheimer's disease	0.000507	0.00244	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR ligand binding—CCL2—Alzheimer's disease	0.000499	0.0024	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000499	0.0024	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PSENEN—Alzheimer's disease	0.00049	0.00236	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	0.000484	0.00233	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APH1A—Alzheimer's disease	0.000483	0.00232	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000478	0.0023	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	0.000475	0.00228	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NCSTN—Alzheimer's disease	0.00047	0.00226	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000468	0.00225	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LRP1—Alzheimer's disease	0.000459	0.00221	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GFAP—Alzheimer's disease	0.000448	0.00216	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GAL—Alzheimer's disease	0.000448	0.00216	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000446	0.00214	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000411	0.00198	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—A2M—Alzheimer's disease	0.000395	0.0019	CbGpPWpGaD
Sulfisoxazole—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000393	0.00189	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000389	0.00187	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PSEN2—Alzheimer's disease	0.000382	0.00184	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000369	0.00177	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000361	0.00174	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000354	0.0017	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPY—Alzheimer's disease	0.000352	0.00169	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IAPP—Alzheimer's disease	0.00035	0.00168	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CRH—Alzheimer's disease	0.00034	0.00163	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCR5—Alzheimer's disease	0.000335	0.00161	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000328	0.00158	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NPS—Alzheimer's disease	0.000322	0.00155	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00032	0.00154	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—F2—Alzheimer's disease	0.000316	0.00152	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PTK2B—Alzheimer's disease	0.000316	0.00152	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GAB2—Alzheimer's disease	0.000307	0.00148	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NTRK2—Alzheimer's disease	0.000307	0.00148	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—SST—Alzheimer's disease	0.000307	0.00148	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CALM1—Alzheimer's disease	0.000306	0.00147	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GSK3A—Alzheimer's disease	0.000304	0.00146	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APP—Alzheimer's disease	0.000299	0.00144	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—F2—Alzheimer's disease	0.000287	0.00138	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PLCB1—Alzheimer's disease	0.000282	0.00136	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	0.000275	0.00132	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NGFR—Alzheimer's disease	0.000263	0.00127	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CREB1—Alzheimer's disease	0.000262	0.00126	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ADAM10—Alzheimer's disease	0.000257	0.00124	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—CCL2—Alzheimer's disease	0.000256	0.00123	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	0.000256	0.00123	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—S100B—Alzheimer's disease	0.000243	0.00117	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CA4—Alzheimer's disease	0.000233	0.00112	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF2—Alzheimer's disease	0.000232	0.00111	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	0.000228	0.0011	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1R—Alzheimer's disease	0.000224	0.00108	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	0.000219	0.00106	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LPL—Alzheimer's disease	0.000215	0.00103	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MEF2C—Alzheimer's disease	0.000213	0.00102	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—PRKCG—Alzheimer's disease	0.000209	0.001	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	0.000208	0.001	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NGF—Alzheimer's disease	0.000203	0.000978	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLD3—Alzheimer's disease	0.000198	0.000955	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.000198	0.000955	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCR5—Alzheimer's disease	0.000198	0.000952	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000196	0.000944	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—HTR2A—Alzheimer's disease	0.000194	0.000931	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	0.00019	0.000915	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000186	0.000894	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	0.000183	0.000881	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CALM1—Alzheimer's disease	0.000181	0.000869	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—APOE—Alzheimer's disease	0.00018	0.000866	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—LEP—Alzheimer's disease	0.00018	0.000866	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CAV1—Alzheimer's disease	0.000178	0.000858	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ND1—Alzheimer's disease	0.000177	0.000851	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000173	0.000832	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—ESR1—Alzheimer's disease	0.000172	0.000827	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—F2—Alzheimer's disease	0.00017	0.000817	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000166	0.000799	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000158	0.000761	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—GSK3B—Alzheimer's disease	0.000156	0.00075	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CREB1—Alzheimer's disease	0.000155	0.000744	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—INS—Alzheimer's disease	0.000154	0.00074	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CCL2—Alzheimer's disease	0.000151	0.000728	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IGF1—Alzheimer's disease	0.000149	0.000716	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000136	0.000656	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—NOS3—Alzheimer's disease	0.000135	0.000649	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000124	0.000597	CbGpPWpGaD
Sulfisoxazole—EDNRA—GPCR downstream signaling—AKT1—Alzheimer's disease	0.000116	0.000556	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—CASP3—Alzheimer's disease	0.000115	0.000551	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CHAT—Alzheimer's disease	0.000114	0.000548	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—TPI1—Alzheimer's disease	0.000114	0.000548	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—IL6—Alzheimer's disease	0.000114	0.000547	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MAOB—Alzheimer's disease	0.000109	0.000526	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—MAPK8—Alzheimer's disease	0.000105	0.000506	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	0.000105	0.000506	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling by GPCR—AKT1—Alzheimer's disease	0.000105	0.000505	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000104	0.0005	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000103	0.000496	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—A2M—Alzheimer's disease	0.000102	0.000489	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—VEGFA—Alzheimer's disease	9.72e-05	0.000467	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.06e-05	0.000436	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TGFB1—Alzheimer's disease	8.92e-05	0.000429	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ACHE—Alzheimer's disease	8.84e-05	0.000425	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	8.74e-05	0.00042	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	8.28e-05	0.000398	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ENO1—Alzheimer's disease	8.28e-05	0.000398	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	8.12e-05	0.000391	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—BCHE—Alzheimer's disease	7.7e-05	0.00037	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—TP53—Alzheimer's disease	7.34e-05	0.000353	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	7.27e-05	0.000349	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.13e-05	0.000343	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	7.04e-05	0.000339	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—IL6—Alzheimer's disease	6.72e-05	0.000323	CbGpPWpGaD
Sulfisoxazole—EDNRA—Signaling Pathways—AKT1—Alzheimer's disease	6.2e-05	0.000298	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	6.07e-05	0.000292	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	6.04e-05	0.000291	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.53e-05	0.000266	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	4.98e-05	0.000239	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.65e-05	0.000224	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.63e-05	0.000223	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.59e-05	0.000221	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.03e-05	0.000194	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—INS—Alzheimer's disease	3.96e-05	0.00019	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.47e-05	0.000167	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.17e-05	0.000153	CbGpPWpGaD
Sulfisoxazole—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.6e-05	7.67e-05	CbGpPWpGaD
